 |
InterPro: IPR000169 Peptidase, cysteine peptidase active site
Protein matches
|
UniProtKB Matches: 4441 proteins |
|
Accession
|
IPR000169 Pept_cys_AS |
Type
|
Active_site |
Signatures
|
|
InterPro Relationships
|
|
Found in
|
IPR013128 Peptidase C1A, papain
IPR015643 Peptidase C1A, cathepsin B
IPR015644 Peptidase C1A, cathepsin K
IPR015645 Peptidase C1A, placentally-expressed cathepsin
|
GO Term annotation
|
|
Process
|
GO:0006508 proteolysis
|
|
Function
|
GO:0004197 cysteine-type endopeptidase activity
|
|
InterPro annotation
|
|
Entry Details in BioMart
|
Abstract
|
In the MEROPS database peptidases and peptidase homologues are grouped into clans and families. Clans are groups of families for which there is evidence of common ancestry based on a common structural fold:
- Each clan is identified with two letters, the first representing the catalytic type of the families included in the clan (with the letter 'P' being used for a clan containing families of more than one of the catalytic types serine, threonine and cysteine). Some families cannot yet be assigned to clans, and when a formal assignment is required, such a family is described as belonging to clan A-, C-, M-, S-, T- or U-, according to the catalytic type. Some clans are divided into subclans because there is evidence of a very ancient divergence within the clan, for example MA(E), the gluzincins, and MA(M), the metzincins.
- Peptidase families are grouped by their catalytic type, the first character representing the catalytic type: A, aspartic; C, cysteine; G, glutamic acid; M, metallo; S, serine; T, threonine; and U, unknown. The serine, threonine and cysteine peptidases utilise the amino acid as a nucleophile and form an acyl intermediate - these peptidases can also readily act as transferases. In the case of aspartic, glutamic and metallopeptidases, the nucleophile is an activated water molecule.
In many instances the structural protein fold that characterises the clan or family may have lost its catalytic activity, yet retain its function in protein recognition and binding.
Cysteine peptidases have characteristic molecular topologies, which can be seen not only in their three-dimensional structures, but commonly also in the two-dimensional structures. These are peptidases in which the nucleophile is the sulphydryl group of a cysteine residue. Cysteine proteases are divided into clans (proteins which are evolutionary related), and further sub-divided into families, on the basis of the architecture of their catalytic dyad or triad [1].
This entry represents the catalytic triad of the cysteine peptidases that are found in the MEROPS peptidase families C1A (papain), C1B (bleomycin hydrolase) and C2 (calpain).
Some of the proteins in this family are also allergens. Allergies are hypersensitivity reactions of the immune system to specific substances called allergens (such as pollen, stings, drugs, or food) that, in most people, result in no symptoms. A nomenclature system has been established for antigens (allergens) that cause IgE-mediated atopic allergies in humans [2]. This nomenclature system is defined by a designation that is composed of
the first three letters of the genus; a space; the first letter of the
species name; a space and an arabic number. In the event that two species
names have identical designations, they are discriminated from one another
by adding one or more letters (as necessary) to each species designation.
The allergens in this family include allergens with the following designations: Der f 1, Der m 1 and Der p 1.
|
Structural links
|
|
Database links
|
|
Additional Reading
|
|
Rawlings ND, Barrett AJ.
Families of cysteine peptidases.
Meth. Enzymol. 244 1994 461-86
[PubMed: 7845226]
http://dx.doi.org/10.1016/0076-6879(94)44034-4
|
|
Li Z, Kienetz M, Cherney MM, James MN, Bromme D.
The crystal and molecular structures of a cathepsin K:chondroitin sulfate complex.
J. Mol. Biol. 383 2008 78-91
[PubMed: 18692071]
http://dx.doi.org/10.1016/j.jmb.2008.07.038
|
|
Velasco G, Ferrando AA, Puente XS, Sanchez LM, Lopez-Otin C.
Human cathepsin O. Molecular cloning from a breast carcinoma, production of the active enzyme in Escherichia coli, and expression analysis in human tissues.
J. Biol. Chem. 269 1994 27136-42
[PubMed: 7929457]
http://intl.jbc.org/cgi/content/abstract/269/43/27136
|
|
Davis TL, Walker JR, Finerty PJ Jr, Mackenzie F, Newman EM, Dhe-Paganon S.
The crystal structures of human calpains 1 and 9 imply diverse mechanisms of action and auto-inhibition.
J. Mol. Biol. 366 2007 216-29
[PubMed: 17157313]
http://dx.doi.org/10.1016/j.jmb.2006.11.037
|
|
Higgins DG, McConnell DJ, Sharp PM.
Malarial proteinase?
Nature 340 1989 604
[PubMed: 2671749]
http://dx.doi.org/10.1038/340604a0
|
|
Shi GP, Chapman HA, Bhairi SM, DeLeeuw C, Reddy VY, Weiss SJ.
Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2.
FEBS Lett. 357 1995 129-34
[PubMed: 7805878]
http://dx.doi.org/10.1016/0014-5793(94)01349-6
|
|
Dufour E.
Sequence homologies, hydrophobic profiles and secondary structures of cathepsins B, H and L: comparison with papain and actinidin.
Biochimie 70 1988 1335-42
[PubMed: 3148320]
http://dx.doi.org/10.1016/0300-9084(88)90004-1
|
|
Qian J, Cuerrier D, Davies PL, Li Z, Powers JC, Campbell RL.
Cocrystal structures of primed side-extending alpha-ketoamide inhibitors reveal novel calpain-inhibitor aromatic interactions.
J. Med. Chem. 51 2008 5264-70
[PubMed: 18702462]
http://dx.doi.org/10.1021/jm800045t
|
|
Stack CM, Caffrey CR, Donnelly SM, Seshaadri A, Lowther J, Tort JF, Collins PR, Robinson MW, Xu W, McKerrow JH, Craik CS, Geiger SR, Marion R, Brinen LS, Dalton JP.
Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica.
J. Biol. Chem. 283 2008 9896-908
[PubMed: 18160404]
http://dx.doi.org/10.1074/jbc.M708521200
|
|
Cuerrier D, Moldoveanu T, Campbell RL, Kelly J, Yoruk B, Verhelst SH, Greenbaum D, Bogyo M, Davies PL.
Development of calpain-specific inactivators by screening of positional scanning epoxide libraries.
J. Biol. Chem. 282 2007 9600-11
[PubMed: 17218315]
http://dx.doi.org/10.1074/jbc.M610372200
|
|